Eedara, B., Tucker, I., & Das, S. (2019). A STELLA simulation model for in vitro dissolution testing of respirable size particles. 9(1). https://doi.org/10.1038/s41598-019-55164-0
2019
Karnes, J., Miller, A., White, L., Konvinse, K., Pavlos, R., Redwood, A., Peter, J., Lehloenya, R., Mallal, S., & Phillips, E. (2019). Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. 59. https://doi.org/10.1146/annurev-pharmtox-010818-021818
Tetuan, C., Axon, D., Bingham, J., Boesen, K., Lipsy, R., Scovis, N., Taylor, A., Warholak, T., Lott, B., & Leal, S. (2019). Assessing the Effect of a Telepharmacist’s Recommendations During an Integrated, Interprofessional Telehealth Appointment and Their Alignment with Quality Measures. 25(12). https://doi.org/10.18553/jmcp.2019.25.12.1334
Huntley, M., Gao, J., Termsarasab, P., Wang, L., Zeng, T., Thammongkolchai, T., Liu, P., Cohen, S., & Wang, L. (2019). Association between TDP-43 and mitochondria in inclusion body myositis. 99(7). https://doi.org/10.1038/s41374-019-0233-x
Alsuhebany, N., Alfehaid, L., Almodaimegh, H., Albekairy, A., & Alharbi, A. (2019). Attitude and Perception of Physicians and Nurses Toward the Role of Clinical Pharmacists in Riyadh, Saudi Arabia: A Qualitative Study. 5.
Haas, C., Appleman, L., Stein, M., Redlinger, M., Wilks, M., Xu, Y.- ming, Onorati, A., Kalavacharla, A., Kim, M., Zhen, C., Kadri, S., Segal, R., Gimotty, P., Davis, L., & Amaravadi, R. (2019). Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma. 25(7). https://doi.org/10.1158/1078-0432.CCR-18-2204
Rangnekar, B., Momin, M., Eedara, B., Sinha, S., & Das, S. (2019). Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis. 570. https://doi.org/10.1016/j.ijpharm.2019.118689
Mi, Y., Yang, S., Bloomquist, C., Xia, M., Sun, B., Qi, Y., Wagner, K., Montgomery, S., Zhang, D., & Wang, L. (2019). Biologically Targeted Photo-Crosslinkable Nanopatch to Prevent Postsurgical Peritoneal Adhesion. 6(19).
Patanwala, A., Radosevich, J., Meshay, I., Naderi, M., Culver, M., Lee, J., Weinberg, J., Khobrani, M., & Nix, D. (2019). Cefazolin Monotherapy Versus Cefazolin Plus Aminoglycosides for Antimicrobial Prophylaxis of Type III Open Fractures. https://doi.org/10.1097/MJT.0000000000001121
Tate, J., Abraham, I., & Cranmer, L. (2019). Center-Specific Modeling Predicts Cancer Trial Accrual More Accurately Than Investigators and Random Effects Modeling at 16 Cancer Centers. 3. https://doi.org/10.1200/CCI.19.00005
Li, X., Fu, P., Green, C., Liu, P., Zhang, D., Lang, Y., Chaturvedi, A., Belfort, M., Liao, G., & Li, X. (2019). Cisplatin protects mice from challenge of by targeting the Prp8 intein. 8(1). https://doi.org/10.1080/22221751.2019.1625727
Andritsos, L., Huang, P.-L., Abraham, I., Huff, K., Scrape, S., Fan, X., Alkhatib, N., Hofmeister, C., Drea, E., & McBride, A. (2019). Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization. 85. https://doi.org/10.1016/j.leukres.2019.106215
Almutairi, A., Alkhatib, N., Martin, J., Babiker, H., Garland, L., McBride, A., & Abraham, I. (2019). Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis. 142. https://doi.org/10.1016/j.critrevonc.2019.07.004
Almulhim, A., Fallatah, S., & Abraham, I. (2019). Comparing incomparables with the wrong analytics: Anticoagulation, disability, intracranial hemorrhage, and mortality in acute cerebral vein thrombosis. 178. https://doi.org/10.1016/j.thromres.2019.04.009
Alhifany, A., Almutairi, A., Almangour, T., Shahbar, A., Abraham, I., Alessa, M., Alnezary, F., & Cheema, E. (2019). Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials. 9(11). https://doi.org/10.1136/bmjopen-2019-031145
Sullivan, S., Dewey, B., Jarrell, B., Vadiei, N., & Patanwala, A. (2019). Comparison of phenobarbital-adjunct versus benzodiazepine-only approach for alcohol withdrawal syndrome in the ED. 37(7). https://doi.org/10.1016/j.ajem.2018.10.007
Fan, X., Li, X., Ding, X., & Zhang, D. (2019). Contributions of Hepatic and Intestinal Metabolism to the Disposition of Niclosamide, A Repurposed Drug with Poor Bioavailability. 47(7).
Barqawi, Y., Borrego, M., Roberts, E., & Abraham, I. (2019). Cost-effectiveness model of abiraterone plus prednisone, cabazitaxel plus prednisone and enzalutamide for visceral metastatic castration resistant prostate cancer therapy after docetaxel therapy resistance. 22(11). https://doi.org/10.1080/13696998.2019.1661581
Eedara, B., Tucker, I., Zujovic, Z., Rades, T., Price, J., & Das, S. (2019). Crystalline adduct of moxifloxacin with trans-cinnamic acid to reduce the aqueous solubility and dissolution rate for improved residence time in the lungs. 136. https://doi.org/10.1016/j.ejps.2019.104961
Jedlowski, P., Te, C., Segal, R., & Fazel, M. (2019). Cutaneous Adverse Effects of Diabetes Mellitus Medications and Medical Devices: A Review. 20(1). https://doi.org/10.1007/s40257-018-0400-7
Mallavadhani, U., Madasu, C., & S., R. (2019). Design, synthesis, anti-inflammatory, cytotoxic and cell based studies of some novel side chain analogues of myrrhanones A & B isolated from the gum resin of Commiphora mukul. 82.
Bime, C., Casanova, N., Oita, R., Ndukum, J., Lynn, H., Camp, S., Lussier, Y., Abraham, I., Carter, D., Miller, A., Mekontso-Dessap, A., Downs, C., & Garcia, J. (2019). Development of a biomarker mortality risk model in acute respiratory distress syndrome. 23(1). https://doi.org/10.1186/s13054-019-2697-x
Hoang, Q., Date, A., Ortiz, J., Young, T.-W., Bensouda, S., Xiao, A., Marzinke, M., Rohan, L., Fuchs, E., Hendrix, C., Gumber, S., Villinger, F., Cone, R., Hanes, J., & Ensign, L. (2019). Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema. 138. https://doi.org/10.1016/j.ejpb.2018.05.030
Ji, Y., Liu, P., Huang, P.-L., Jiang, J., Liao, G., Liu, P., Chang, C.-Y., Liao, G., Lu, J., Wang, L., Spencer, M., & Meng, H. (2019). Development of self-assembled multi-arm polyrotaxanes nanocarriers for systemic plasmid delivery in vivo. 192. https://doi.org/10.1016/j.biomaterials.2018.11.027
Pagination
- First page
- …
- 9
- 10
- 11
- …
- Last page